Keyword Suggestion
Domain Informations
Bexsero.com lookup results from whois.safenames.net server:
- Domain created: 2009-11-11T20:42:09Z
- Domain updated: 2023-11-12T00:59:19Z
- Domain expires: 2024-11-11T20:42:09Z 0 Years, 195 Days left
- Website age: 14 Years, 170 Days
- Registrar Domain ID: 1575403592_DOMAIN_COM-VRSN
- Registrar Url: http://www.safenames.net
- Registrar WHOIS Server: whois.safenames.net
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +44.1908200022
- Name server:
- NS-1070.AWSDNS-05.ORG
- NS-1601.AWSDNS-08.CO.UK
- NS-87.AWSDNS-10.COM
- NS-999.AWSDNS-60.NET
Network
- inetnum : 34.64.0.0 - 34.127.255.255
- name : GOOGL-2
- handle : NET-34-64-0-0-1
- status : Direct Allocation
- created : 2006-09-29
- changed : 2019-11-01
- desc : *** The IP addresses under this Org-ID are in use by Google Cloud customers ***,Direct all copyright and legal complaints to,https://support.google.com/legal/go/report,Direct all spam and abuse complaints to,https://support.google.com/code/go/gce_abuse_report,For fastest response, use the relevant forms above.,Complaints can also be sent to the GC Abuse desk,([email protected]),but may have longer turnaround times.,Complaints sent to any other POC will be ignored.
Owner
- organization : Google LLC
- handle : GOOGL-2
- address : Array,Mountain View,CA,94043,US
Abuse
- handle : GCABU-ARIN
- name : GC Abuse
- phone : +1-650-253-0000
- email : [email protected]
Technical support
- handle : ZG39-ARIN
- name : Google LLC
- phone : +1-650-253-0000
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 286730 |
namecheap.com | 101387 |
networksolutions.com | 69118 |
tucows.com | 52617 |
publicdomainregistry.com | 39120 |
whois.godaddy.com | 32793 |
enomdomains.com | 23825 |
namesilo.com | 21429 |
domains.google.com | 21384 |
cloudflare.com | 20573 |
gmo.jp | 18110 |
name.com | 17601 |
fastdomain.com | 14708 |
register.com | 13495 |
net.cn | 12481 |
ionos.com | 12416 |
ovh.com | 12416 |
gandi.net | 12305 |
registrar.amazon.com | 12111 |
Host Informations
- IP address: 34.107.225.66
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 34.107.225.66)
Spam Check (IP: 34.107.225.66)
Recent Searched Sites
› Ranjoganj.ir (45 seconds ago) / IR
› Koreader.rocks (17 seconds ago) / US
› Neginshargh.com (1 seconds ago) / IR
› Talentry.com (23 seconds ago) / CA
› Csc.gov.au (11 seconds ago) / US
› Bexsero.com (0 seconds ago) / US
› Blog6.info (29 seconds ago) / TW
› Thundershare.net (4 seconds ago) / US
› Gracechurch.us (15 seconds ago) / US
› Weather.meteostar.com (1 mins ago) / US
› Liveinlog.com (11 seconds ago) / US
› Nimiti.org (37 seconds ago) / US
› Kencolemusic.com (2 seconds ago) / US
› Ahvaz.iau.ir (4 seconds ago) / IR
› Offer.buybyecritter.com (0 seconds ago) / US
› Farmingtonfamilydental.com (7 seconds ago) / US
› Psyop.com (3 seconds ago) / US
› M.huarenstore.com (9 seconds ago) / US
› Mediniqhealthcare.com (33 seconds ago) / US
› Alcoholism-addiction.conferenceseries.com (7 seconds ago) / US
Websites Listing
We found Websites Listing below when search with bexsero.com on Search Engine
BEXSERO CANADA - Meningitis B vaccination and …
BEXSERO multicomponent meningococcal B vaccine (recombinant, adsorbed) is a vaccine for the prevention of meningococcal disease caused by Neisseria meningitidis group B bacteria in individuals from 2 months through 25 years of age. BEXSERO is not expected to protect against all circulating meningococcal serogroup B strains and does not offer protection against strains …
Bexsero.caBEXSERO CANADA – Dose Reminder
BEXSERO multicomponent meningococcal B vaccine (recombinant, adsorbed) is a vaccine for the prevention of meningococcal disease caused by Neisseria meningitidis group B bacteria in individuals from 2 months through 25 years of age. BEXSERO is not expected to protect against all circulating meningococcal serogroup B strains and does not offer protection against strains …
Bexsero.caBEXSERO | GSK Canada
Group 21. Created with Sketch. In all of our interactions with HCPs we aim to be transparent about our work, operate with integrity, and always put our patients first. ×. Where we operate. You are currently visiting our Canada website. Global https://www.gsk.com. Africa. Group 21.
Ca.gsk.comBexsero - FDA prescribing information, side effects and uses
2022-01-01 · Bexsero is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Bexsero is approved for use in individuals aged 10 through 25 years. Approval of Bexsero is based on demonstration of immune response, as measured by serum bactericidal activity against three serogroup B strains ...
Drugs.comDosing and administration - GSKpro
Recommended dosing schedule for BEXSERO 1. * The need for, and timing of further doses has not yet been determined. BEXSERO should be given by deep intramuscular injection, preferably in the anterolateral aspect of the thigh in infants or in the deltoid muscle region of the upper arm in older subjects. The vaccine must not be mixed with other ...
Gskpro.comResources - GSKpro
BEXSERO resources. If you would like to receive printed copies of any of these resources for your practice, please contact your GSK Customer Response Center at 1-800-387-7374.
Gskpro.comBexsero Product Monograph - GSK
BEXSERO, Multicomponent Meningococcal B Vaccine Page 8 of 54 acetaminophen at the time of, and closely after vaccination, can reduce the incidence and intensity of post-vaccination febrile reactions in infants and children (less than 2 years of age). Administration of BEXSERO should be postponed in individuals suffering from an acute severe febrile illness. However, the presence …
Ca.gsk.comMeningococcal B Vaccine (Bexsero®): Information for high risk ...
(4CMenB or Bexsero ®) to individuals with high risk conditions from 2 months through 17 years of age with the following conditions: a. Individuals with functional or anatomic asplenia b. Individuals with complement, properdin, factor D or primary antibody deficiencies c. Cochlear implant recipients (pre/post implants) d. Individuals with ...
Health.gov.on.caMeningococcal B Vaccine (Bexsero®): Q&A for health care providers
About the publicly funded M eningococcal B Vaccine (Bexsero ®) In December 2013, Health Canada approved Bexsero ®, a novel multicomponent meningococcal B vaccine (4CMenB), manufactured by Novartis. Bexsero ® protects against meningococcal serogroup B disease, and has been authorized for use in individuals 2 months through 17 years of age.
Health.gov.on.ca必思諾 B 型腦膜炎雙球菌疫苗 - GSK
Bexsero: 的核准是基於施打疫苗後針對特殊菌株的免疫反應(serum bactericidal activity),其對於其他多種不同菌株的B 型奈瑟氏腦膜炎雙球菌的疫苗效果尚未確 認,施打Bexsero 應考量不同區域流行的B 型奈瑟氏腦膜炎雙球菌菌株。Bexsero 應遵照官方建議使用。 劑量與用法
Tw.gsk.comDosing | BEXSERO (Meningococcal Group B Vaccine) Info for HCPs
BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO is approved for use in individuals aged 10 through 25 years.. Approval of BEXSERO is based on demonstration of immune response, as measured by serum bactericidal activity against three serogroup B strains representative of prevalent …
Bexserohcp.comBEXSERO - MesVaccins.net
BEXSERO. Vaccin disponible. La primovaccination des nourrissons âgés de 2 à 5 mois peut être réalisée avec deux doses espacées de deux mois au …
Mesvaccins.netBexsero®: First Vaccine to Prevent Meningococcal Serogroup B …
2014-02-26 · Bexsero ® is the result of more than 40 years of pioneering vaccine research. 6 The tolerability profile and immunogenicity of Bexsero ® have been established through a comprehensive clinical ...
Newswire.caBEXSERO | FDA
2022-01-07 · BEXSERO. STN: BL 125546. Proper Name: Meningococcal Group B Vaccine. Trade Name: BEXSERO. Manufacture: GlaxoSmithKline. Indication: Active immunization to prevent invasive disease caused by ...
Fda.govBexsero (Meningococcal Group B Vaccine): Uses, Dosage, Side
2022-05-11 · INDICATIONS. BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO is approved for use in individuals 10 through 25 years of age.. Approval of BEXSERO is based on demonstration of immune response, as measured by serum bactericidal activity against three serogroup B …
Rxlist.comBexsero :: WoWProgress - World of Warcraft Rankings
Detailed character history for Bexsero, EU-Taerar: loot history, guilds, build changes
Wowprogress.comBexsero - Impfstoff - Kinderarzt.net
Preis inkl Impfgebühr in unserer Kinderarztpraxis: 130 Euro. 1. Bezeichnung. Bexsero Injektionssuspension in einer Fertigspritze, Impfstoff gegen Meningokokken der Gruppe B (rDNA, Komponenten, adsorbiert) 2. Zusammensetzung von Bexsero. Eine Dosis (0,5 ml) enthält: Rekombinantes NHBA-Fusionsprotein von Neisseria meningitidis der Gruppe B 1,2,3.
Kinderarzt.netPackage Insert - BEXSERO (Meningococcal Group B Vaccine)
BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO is approvedfor use in i ndividuals 10 through 25 years of age. (1) Approval of BEXSERO is based on demonstration of immune response, as measured by serum bactericidal activity against three serogroup B strains representative of …
Pubmedinfo.orgBexsero | Immunisation Advisory Centre
Bexsero ®, a multicomponent recombinant vaccine against meningococcal group B disease only is available in New Zealand. Bexsero was first approved for use in Europe in 2013, since then the vaccine has been approved for use in more than 40 countries including Australia, the United Kingdom and the United States. Conjugated meningococcal vaccines that protect against …
Immune.org.nzBexsero - Pediatrics - Jul Display Banners HCP Wallboard Extension ...
Bexsero – Pediatrics – Jul Display Banners HCP Wallboard Extension – 22743. Childhood Bedtime Before 9:00pm Cuts Overweight & Obesity Risk by One-Third. Jun 1, 2022 “ Previous research has shown that longer sleep duration is tied to lower adiposity and weight status in youth,” explains Paul J. Collings, PhD. “Parameters such as bedtimes and sleep quality may …
Physiciansweekly.com
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
kokosrestaurant.com | godaddy.com | -2 Years, -30 Days |
dusdata.com | godaddy.com | -1 Years, -121 Days |
forbiddenteens1.top | namesilo.com | -1 Years, -152 Days |
bemaziesconsult.com | ownregistrar.com | -2 Years, -43 Days |
keyanlib.com | west.cn | 296 Days |
fyzbw.com | enomdomains.com | -1 Years, -74 Days |
osx9.com | namesilo.com | -1 Years, -330 Days |
seebeyondmag.com | namecheap.com | -1 Years, -46 Days |
acpsm.org | porkbun.com | -1 Years, -335 Days |
effikos.com | enomdomains.com | -2 Years, -51 Days |